Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 109

1.

Autocrine STAT3 activation in HPV positive cervical cancer through a virus-driven Rac1-NFκB-IL-6 signalling axis.

Morgan EL, Macdonald A.

PLoS Pathog. 2019 Jun 21;15(6):e1007835. doi: 10.1371/journal.ppat.1007835. [Epub ahead of print]

2.

Effects of Changes in Apnea Time on the Clinical Status of Neonates on NIV-NAVA.

Morgan EL, Firestone KS, Schachinger SW, Stein HM.

Respir Care. 2019 Jun 4. pii: respcare.06662. doi: 10.4187/respcare.06662. [Epub ahead of print]

PMID:
31164483
3.

Author's Right of Reply: Cervical cancer in women under 25 years of age in Queensland, Australia: To what extent is the diagnosis made by screening cytology?

Nicklin J, Morgan EL.

Aust N Z J Obstet Gynaecol. 2018 Jun;58(3):E6. doi: 10.1111/ajo.12801. No abstract available.

PMID:
29864217
4.

STAT3 activation by E6 is essential for the differentiation-dependent HPV18 life cycle.

Morgan EL, Wasson CW, Hanson L, Kealy D, Pentland I, McGuire V, Scarpini C, Coleman N, Arthur JSC, Parish JL, Roberts S, Macdonald A.

PLoS Pathog. 2018 Apr 9;14(4):e1006975. doi: 10.1371/journal.ppat.1006975. eCollection 2018 Apr.

5.

Agnoprotein Is an Essential Egress Factor during BK Polyomavirus Infection.

Panou MM, Prescott EL, Hurdiss DL, Swinscoe G, Hollinshead M, Caller LG, Morgan EL, Carlisle L, Müller M, Antoni M, Kealy D, Ranson NA, Crump CM, Macdonald A.

Int J Mol Sci. 2018 Mar 19;19(3). pii: E902. doi: 10.3390/ijms19030902.

6.

Human papillomavirus type 18 E5 oncogene supports cell cycle progression and impairs epithelial differentiation by modulating growth factor receptor signalling during the virus life cycle.

Wasson CW, Morgan EL, Müller M, Ross RL, Hartley M, Roberts S, Macdonald A.

Oncotarget. 2017 Oct 6;8(61):103581-103600. doi: 10.18632/oncotarget.21658. eCollection 2017 Nov 28.

7.

Cervical cancer in women under 25 years of age in Queensland, Australia: To what extent is the diagnosis made by screening cytology?

Morgan EL, Sanday K, Budd A, Hammond IG, Nicklin J.

Aust N Z J Obstet Gynaecol. 2017 Aug;57(4):469-472. doi: 10.1111/ajo.12640. Epub 2017 Jun 4.

PMID:
28580578
8.

New Structural Insights into the Genome and Minor Capsid Proteins of BK Polyomavirus using Cryo-Electron Microscopy.

Hurdiss DL, Morgan EL, Thompson RF, Prescott EL, Panou MM, Macdonald A, Ranson NA.

Structure. 2016 Apr 5;24(4):528-536. doi: 10.1016/j.str.2016.02.008. Epub 2016 Mar 17.

9.

A novel C5a-derived immunobiotic peptide reduces Streptococcus agalactiae colonization through targeted bacterial killing.

Cavaco CK, Patras KA, Zlamal JE, Thoman ML, Morgan EL, Sanderson SD, Doran KS.

Antimicrob Agents Chemother. 2013 Nov;57(11):5492-9. doi: 10.1128/AAC.01590-13. Epub 2013 Aug 26.

10.

An agonist of human complement fragment C5a enhances vaccine immunity against Coccidioides infection.

Hung CY, Hurtgen BJ, Bellecourt M, Sanderson SD, Morgan EL, Cole GT.

Vaccine. 2012 Jun 29;30(31):4681-90. doi: 10.1016/j.vaccine.2012.04.084. Epub 2012 May 8.

11.

Control of methicillin resistant Staphylococcus aureus infection utilizing a novel immunostimulatory peptide.

Sheen TR, Cavaco CK, Ebrahimi CM, Thoman ML, Sanderson SD, Morgan EL, Doran KS.

Vaccine. 2011 Dec 9;30(1):9-13. doi: 10.1016/j.vaccine.2011.10.054. Epub 2011 Oct 30.

12.

Interaction between eicosanoids and the complement system in salmonid fish.

Rowley AF, Morgan EL, Taylor GW, Sunyer JO, Holland JW, Vogan CL, Secombes CJ.

Dev Comp Immunol. 2012 Jan;36(1):1-9. doi: 10.1016/j.dci.2011.05.007. Epub 2011 Jun 1.

PMID:
21658408
13.

A novel adjuvant for vaccine development in the aged.

Morgan EL, Thoman ML, Sanderson SD, Phillips JA.

Vaccine. 2010 Dec 6;28(52):8275-9. doi: 10.1016/j.vaccine.2010.10.008. Epub 2010 Oct 19.

14.

Enhancement of in vivo and in vitro immune functions by a conformationally biased, response-selective agonist of human C5a: implications for a novel adjuvant in vaccine design.

Morgan EL, Morgan BN, Stein EA, Vitrs EL, Thoman ML, Sanderson SD, Phillips JA.

Vaccine. 2009 Dec 11;28(2):463-9. doi: 10.1016/j.vaccine.2009.10.029. Epub 2009 Oct 15.

15.

Single-step conjugation of bioactive peptides to proteins via a self-contained succinimidyl bis-arylhydrazone.

Phillips JA, Morgan EL, Dong Y, Cole GT, McMahan C, Hung CY, Sanderson SD.

Bioconjug Chem. 2009 Oct 21;20(10):1950-7. doi: 10.1021/bc9002794. Epub 2009 Sep 29.

16.

Pre-spliceosomal binding of U1 small nuclear ribonucleoprotein (RNP) and heterogenous nuclear RNP E1 is associated with suppression of a growth hormone receptor pseudoexon.

Akker SA, Misra S, Aslam S, Morgan EL, Smith PJ, Khoo B, Chew SL.

Mol Endocrinol. 2007 Oct;21(10):2529-40. Epub 2007 Jul 10.

PMID:
17622584
17.

Apical GLUT2 and Cav1.3: regulation of rat intestinal glucose and calcium absorption.

Morgan EL, Mace OJ, Affleck J, Kellett GL.

J Physiol. 2007 Apr 15;580(Pt. 2):593-604. Epub 2007 Feb 1.

18.

Calcium absorption by Cav1.3 induces terminal web myosin II phosphorylation and apical GLUT2 insertion in rat intestine.

Mace OJ, Morgan EL, Affleck JA, Lister N, Kellett GL.

J Physiol. 2007 Apr 15;580(Pt. 2):605-16. Epub 2007 Feb 1.

19.

Rainbow trout (Oncorhynchus mykiss) brain cells biosynthesize novel docosahexaenoic acid-derived resolvins and protectins-Mediator lipidomic analysis.

Hong S, Tjonahen E, Morgan EL, Lu Y, Serhan CN, Rowley AF.

Prostaglandins Other Lipid Mediat. 2005 Dec;78(1-4):107-16. Epub 2005 Jun 13.

PMID:
16303609
20.
21.

Australia was indeed the "lucky country" in the recent worldwide SARS epidemic.

Jauncey ME, Armstrong PK, Morgan EL, McAnulty JM.

Med J Aust. 2004 Aug 16;181(4):229-30. No abstract available.

PMID:
15310266
22.

Stress and glucocorticoid inhibit apical GLUT2-trafficking and intestinal glucose absorption in rat small intestine.

Shepherd EJ, Helliwell PA, Mace OJ, Morgan EL, Patel N, Kellett GL.

J Physiol. 2004 Oct 1;560(Pt 1):281-90. Epub 2004 Aug 5.

23.

A role for Ca(v)1.3 in rat intestinal calcium absorption.

Morgan EL, Mace OJ, Helliwell PA, Affleck J, Kellett GL.

Biochem Biophys Res Commun. 2003 Dec 12;312(2):487-93.

PMID:
14637163
24.

Expression of receptors for C5a anaphylatoxin (CD88) on human bronchial epithelial cells: enhancement of C5a-mediated release of IL-8 upon exposure to cigarette smoke.

Floreani AA, Heires AJ, Welniak LA, Miller-Lindholm A, Clark-Pierce L, Rennard SI, Morgan EL, Sanderson SD.

J Immunol. 1998 May 15;160(10):5073-81.

26.

Molecular adjuvant effects of a conformationally biased agonist of human C5a anaphylatoxin.

Tempero RM, Hollingsworth MA, Burdick MD, Finch AM, Taylor SM, Vogen SM, Morgan EL, Sanderson SD.

J Immunol. 1997 Feb 1;158(3):1377-82.

PMID:
9013982
29.

Induction of interleukin-8 synthesis from monocytes by human C5a anaphylatoxin.

Ember JA, Sanderson SD, Hugli TE, Morgan EL.

Am J Pathol. 1994 Feb;144(2):393-403.

30.
31.

Identification and characterization of the effector region within human C5a responsible for stimulation of IL-6 synthesis.

Morgan EL, Sanderson S, Scholz W, Noonan DJ, Weigle WO, Hugli TE.

J Immunol. 1992 Jun 15;148(12):3937-42.

PMID:
1602137
32.

Fibronectin augments anti-CD3-mediated IL-2 receptor (CD25) expression on human peripheral blood lymphocytes.

Cardarelli PM, Yamagata S, Scholz W, Moscinski MA, Morgan EL.

Cell Immunol. 1991 Jun;135(1):105-17.

PMID:
1826861
33.

C5a-mediated release of interleukin 6 by human monocytes.

Scholz W, McClurg MR, Cardenas GJ, Smith M, Noonan DJ, Hugli TE, Morgan EL.

Clin Immunol Immunopathol. 1990 Nov;57(2):297-307.

PMID:
2208809
34.

Suppression of human B lymphocyte activation by beta-endorphin.

Morgan EL, McClurg MR, Janda JA.

J Neuroimmunol. 1990 Aug;28(3):209-17.

PMID:
2142691
35.

Induction of human B cell differentiation by Fc region activators. II. Stimulation of IL-6 production.

Morgan EL, Hobbs MV, Thoman ML, Janda J, Noonan DJ, Kadar J, Weigle WO.

J Immunol. 1990 Apr 1;144(7):2499-505.

PMID:
2319130
36.

Roentgenographic measurement of pedicle screw penetration.

Whitecloud TS, Skalley TC, Cook SD, Morgan EL.

Clin Orthop Relat Res. 1989 Aug;(245):57-68. Review.

PMID:
2665995
37.

Induction of human B cell differentiation by Fc region activators. I. Identification of an active tetrapeptide.

Hobbs MV, Houghten RA, Janda JA, Weigle WO, Morgan EL.

Clin Immunol Immunopathol. 1989 Feb;50(2):251-63.

PMID:
2783666
38.

Induction of IL-1 secretion from human monocytes by Fc region subfragments of human IgG1.

Morgan EL, Hobbs MV, Noonan DJ, Weigle WO.

J Immunol. 1988 May 1;140(9):3014-20.

PMID:
3258890
39.

Trabecular bone density and menstrual function in women runners.

Cook SD, Harding AF, Thomas KA, Morgan EL, Schnurpfeil KM, Haddad RJ Jr.

Am J Sports Med. 1987 Sep-Oct;15(5):503-7.

PMID:
3674275
40.

Association of bone mineral density and pediatric fractures.

Cook SD, Harding AF, Morgan EL, Doucet HJ, Bennett JT, O'Brien M, Thomas KA.

J Pediatr Orthop. 1987 Jul-Aug;7(4):424-7.

PMID:
3611339
41.
42.

Identification of a lymphocyte-activating pentapeptide sequence in the Fc region of human IgG1.

Hobbs MV, Morgan EL, Houghten RA, Thoman ML, Weigle WO.

J Immunol. 1987 Apr 15;138(8):2581-6.

PMID:
3494079
43.

Modulation of the induction and circumvention of immunological tolerance to human gamma-globulin by interleukin 1.

Weigle WO, Scheuer WV, Hobbs MV, Morgan EL, Parks DE.

J Immunol. 1987 Apr 1;138(7):2069-74.

PMID:
2435789
44.

Trabecular bone mineral density in idiopathic scoliosis.

Cook SD, Harding AF, Morgan EL, Nicholson RJ, Thomas KA, Whitecloud TS, Ratner ES.

J Pediatr Orthop. 1987 Mar-Apr;7(2):168-74.

PMID:
3558800
45.

Biological activities residing in the Fc region of immunoglobulin.

Morgan EL, Weigle WO.

Adv Immunol. 1987;40:61-134. Review. No abstract available.

PMID:
3109222
46.

Antagonistic regulatory properties of the Fc region of immunoglobulin.

Morgan EL, Scheuer WV, Hobbs MV.

Immunopharmacology. 1986 Dec;12(3):221-32.

PMID:
3102401
47.

Lymphocyte activation by the Fc region of immunoglobulins.

Morgan EL, Hobbs MV, Thoman MT, Weigle WO.

Immunol Invest. 1986 Nov;15(7):625-87. Review.

PMID:
3100442
48.

Modulation of the immune response by anaphylatoxins.

Morgan EL.

Complement. 1986;3(3):128-36. Review.

PMID:
3542364
49.
50.

Salivary gland lymphocytes in primary Sjogren's syndrome lack lymphocyte subsets defined by Leu-7 and Leu-11 antigens.

Fox RI, Hugli TE, Lanier LL, Morgan EL, Howell F.

J Immunol. 1985 Jul;135(1):207-14.

PMID:
3923102

Supplemental Content

Loading ...
Support Center